| Taurine | Approved Investigational Nutraceutical | SMC3 | 9126 |
upregulated | Taurine results in increased expression of SMC3 mRNA | 10q25.2 | |
| Taurine | Approved Investigational Nutraceutical | SNAPC5 | 10302 |
upregulated | Taurine results in increased expression of SNAPC5 mRNA | 15q22.31 | |
| Taurine | Approved Investigational Nutraceutical | SPRY2 | 10253 |
upregulated | Taurine results in increased expression of SPRY2 mRNA | 13q31.1 | |
| Taurine | Approved Investigational Nutraceutical | SRP54 | 6729 |
downregulated | Taurine results in decreased expression of SRP54 mRNA | 14q13.2 | |
| Taurine | Approved Investigational Nutraceutical | STAT3 | 6774 |
downregulated | Taurine results in decreased expression of STAT3 mRNA | 17q21.2 | |
| Taurine | Approved Investigational Nutraceutical | TACR1 | 6869 |
downregulated | Taurine results in decreased expression of TACR1 mRNA | 2p12 | |
| Taurine | Approved Investigational Nutraceutical | TEK | 7010 |
upregulated | Taurine results in increased expression of TEK mRNA | 9p21.2 | |
| Taurine | Approved Investigational Nutraceutical | TP53I3 | 9540 |
downregulated | Taurine results in decreased expression of TP53I3 mRNA | 2p23.3 | |
| Taurine | Approved Investigational Nutraceutical | TYK2 | 7297 |
downregulated | Taurine results in decreased expression of TYK2 mRNA | 19p13.2 | |
| Taurine | Approved Investigational Nutraceutical | VCP | 7415 |
downregulated | Taurine results in decreased expression of VCP mRNA | 9p13.3 | |
| Taurine | Approved Investigational Nutraceutical | XRCC4 | 7518 |
upregulated | Taurine results in increased expression of XRCC4 mRNA | 5q14.2 | |
| Taurocholic acid | Approved | BLVRA | 644 |
upregulated | Taurocholic Acid results in increased expression of BLVRA mRNA | 7p13 | |
| Taurocholic acid | Approved | CCND1 | 595 |
upregulated | Taurocholic Acid results in increased expression of CCND1 mRNA | 11q13.3 | |
| Taurocholic acid | Approved | IL6 | 3569 |
upregulated | Taurocholic Acid results in increased expression of IL6 mRNA | 7p15.3 | |
| Taurocholic acid | Approved | MMP2 | 4313 |
upregulated | Taurocholic Acid results in increased expression of MMP2 mRNA | 16q12.2 | |
| Taurocholic acid | Approved | MMP9 | 4318 |
upregulated | Taurocholic Acid results in increased expression of MMP9 mRNA | 20q13.12 | |
| Taurocholic acid | Approved | NR0B2 | 8431 |
upregulated | Taurocholic Acid results in increased expression of NR0B2 mRNA | 1p36.11 | |
| Taurocholic acid | Approved | NR1H4 | 9971 |
upregulated | Taurocholic Acid results in increased expression of NR1H4 mRNA | 12q23.1 | |
| Taurocholic acid | Approved | NR1I2 | 8856 |
upregulated | Taurocholic Acid results in increased expression of NR1I2 mRNA | 3q13.33 | |
| Taurocholic acid | Approved | SLC23A1 | 9963 |
upregulated | Taurocholic Acid results in increased expression of SLC23A1 mRNA | 5q31.2 | |
| Taurocholic acid | Approved | SLC23A2 | 9962 |
upregulated | Taurocholic Acid results in increased expression of SLC23A2 mRNA | 20p13 | |
| Taurocholic acid | Approved | TNF | 7124 |
upregulated | Taurocholic Acid results in increased expression of TNF mRNA | 6p21.33 | |
| Tauroursodeoxycholic acid | Approved Investigational Withdrawn | ATF4 | 468 |
downregulated | tauroursodeoxycholic acid results in decreased expression of ATF4 mRNA | 22q13.1 | |
| Tauroursodeoxycholic acid | Approved Investigational Withdrawn | FABP4 | 2167 |
downregulated | tauroursodeoxycholic acid results in decreased expression of FABP4 mRNA | 8q21.13 | |
| Tauroursodeoxycholic acid | Approved Investigational Withdrawn | GPBAR1 | 151306 |
downregulated | tauroursodeoxycholic acid results in decreased expression of GPBAR1 mRNA | 2q35 | |